Search Results - "SCHOEN, R. T"

Refine Results
  1. 1

    Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant by Steere, Allen C, Sikand, Vijay K, Meurice, François, Parenti, Dennis L, Fikrig, Erol, Schoen, Robert T, Nowakowski, John, Schmid, Christopher H, Laukamp, Sabine, Buscarino, Charles, Krause, David S

    Published in The New England journal of medicine (23-07-1998)
    “…Lyme disease, which is caused by the tick-borne spirochete Borrelia burgdorferi, is now the most common vector-borne disease in the United States. 1 Since the…”
    Get full text
    Journal Article
  2. 2

    The consequences of Overdiagnosis and overtreatment of Lyme disease : An observational study by REID, M. C, SCHOEN, R. T, EVANS, J, ROSENBERG, J. C, HORWITZ, R. I

    Published in Annals of internal medicine (01-03-1998)
    “…The adverse consequences associated with overdiagnosis and overtreatment of Lyme disease, although previously recognized, have received inadequate attention…”
    Get full text
    Journal Article
  3. 3

    The clinical evolution of Lyme arthritis by Steere, A C, Schoen, R T, Taylor, E

    Published in Annals of internal medicine (01-11-1987)
    “…To determine the clinical evolution of Lyme arthritis, 55 patients who did not receive antibiotic therapy for erythema chronicum migrans were followed…”
    Get more information
    Journal Article
  4. 4

    Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage by Schoen, R T, Vender, R J

    Published in The American journal of medicine (01-04-1989)
    “…The effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric mucosa are well documented. The complex mechanisms of gastric damage, however, are…”
    Get more information
    Journal Article
  5. 5

    The Lyme disease vaccine : Conception, development, and implementation by THANASSI, W. T, SCHOEN, R. T

    Published in Annals of internal medicine (18-04-2000)
    “…In the past 20 years, remarkable strides have been made toward understanding and preventing Lyme disease in humans. In December 1998, the U.S. Food and Drug…”
    Get full text
    Journal Article
  6. 6

    Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease by Schoen, Robert T., Meurice, Francois, Brunet, Cristina M., Cretella, Stella, Krause, David S., Craft, Joe E., Fikrig, Erol

    Published in The Journal of infectious diseases (01-11-1995)
    “…The safety and immunogenicity of a recombinant outer surface protein A (OspA) Lyme vaccine in patients previously diagnosed with Lyme disease was assessed in a…”
    Get full text
    Journal Article
  7. 7

    Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice by Fikrig, Erol, Flavell, Richard A, Alexopoulou, Lena, Thomas, Venetta, Schnare, Markus, Lobet, Yves, Anguita, Juan, Schoen, Robert T, Medzhitov, Ruslan

    Published in Nature Medicine (01-08-2002)
    “…The Lyme disease vaccine is based on the outer-surface lipoprotein (OspA) of the pathogen Borrelia burgdorferi, and 95% of vaccine recipients develop…”
    Get full text
    Journal Article Magazine Article
  8. 8

    Differential Expression of Borrelia burgdorferi Genes during Erythema Migrans and Lyme Arthritis by Fikrig, Erol, Feng, Wen, Aversa, John, Schoen, Robert T., Flavell, Richard A.

    Published in The Journal of infectious diseases (01-10-1998)
    “…Borrelia burgdorferi, the agent of Lyme disease, selectively expresses genes in the arthropod vector and mammalian host. Specific B. burgdorferi gene…”
    Get full text
    Journal Article
  9. 9

    Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection by ZHANG, Y.-Q, MATHIESEN, D, KOLBERT, C. P, ANDERSON, J, SCHOEN, R. T, FIKRIG, E, PERSING, D. H

    Published in Journal of Clinical Microbiology (01-01-1997)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10

    Safety and immunogenicity profile of a recombinant outer-surface protein a Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months by Schoen, Robert T., Sikand, Vijay K., Caldwell, Michael C., Van Hoecke, C., Gillet, Marc, Buscarino, Charles, Parenti, Dennis L.

    Published in Clinical therapeutics (01-03-2000)
    “…This study compared the tolerability of a Lyme disease vaccine administered intramuscularly at 0 and 1 months with that of a vaccine administered at 0, 1, and…”
    Get full text
    Journal Article
  11. 11

    Identification of Lyme disease by Schoen, R T

    “…The identification of Lyme disease is an important, rewarding process. In early disease, the presence of EM, the geographic location of the patient, and the…”
    Get more information
    Journal Article
  12. 12

    Successful parenteral penicillin therapy of established Lyme arthritis by Steere, A C, Green, J, Schoen, R T, Taylor, E, Hutchinson, G J, Rahn, D W, Malawista, S E

    Published in The New England journal of medicine (04-04-1985)
    “…In a double-blind placebo-controlled trial carried out from 1980 to 1982, 20 patients with established Lyme arthritis were assigned treatment with 2.4 million…”
    Get more information
    Journal Article
  13. 13

    Asymptomatic Infection with Borrelia burgdorferi by Steere, Allen C., Sikand, Vijay K., Schoen, Robert T., Nowakowski, John

    Published in Clinical infectious diseases (15-08-2003)
    “…The natural history of asymptomatic seroconversion to Borrelia burgdorferi has been unclear. We report here, on the basis of a post hoc assessment, the…”
    Get full text
    Journal Article
  14. 14

    Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells by Schoen, RT, Greene, MI, Trentham, DE

    Published in The Journal of immunology (1950) (01-02-1982)
    “…The induction of arthritis in Wistar-Lewis rats was suppressed by i.v. injections of spleen cells coupled to native type II collagen, beginning 14 days before…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Autoimmunity induced by type II collagen-coupled spleen cells by Schoen, R T, Mehlman, H, Trentham, D E, Perry, L, Greene, M I, David, J R

    Published in The Journal of immunology (1950) (01-12-1981)
    “…Reactivity to self was induced by injecting rats subcutaneously (s.c.) with spleen cells coupled to native homologous or heterologous type II collagens. Native…”
    Get full text
    Journal Article
  18. 18

    Lyme disease by Evans, J, Schoen, R T

    Published in Current opinion in rheumatology (01-07-1993)
    “…In 1992, reported Lyme disease cases increased, but the majority remained clustered in the northeast and midwest, and in California. The clinical syndromes…”
    Get more information
    Journal Article
  19. 19

    Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy by Schoen, R T, Aversa, J M, Rahn, D W, Steere, A C

    Published in Arthritis and rheumatism (01-08-1991)
    “…Of 20 patients who underwent arthroscopic synovectomy for refractory chronic Lyme arthritis of the knee, 16 (80%) had resolution of joint inflammation during…”
    Get more information
    Journal Article
  20. 20

    Pathogenesis, diagnosis, manifestations, and treatment of Lyme disease by Schoen, R T

    Published in Current opinion in rheumatology (01-08-1991)
    “…Progress in understanding the causation and immunopathogenesis of Lyme disease has continued in the past year. Only by studying the complex relationship…”
    Get more information
    Journal Article